High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$13.7M
$13,684,646
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-03-02
$164,876
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $164,876 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$153,629
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $153,629 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-03-02
$4,690
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $4,690 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $69,745 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $2,099 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -16.7%
2026-03-02
$256,518
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -16.7%
|
2026-03-02 | $256,518 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Leonard Keith R
• Director
10b5-1 SellΔOwn -64.0%
2026-03-02
$997,195
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -64.0%
|
2026-03-02 | $997,195 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2026-03-02 | $91,772 | M | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2026-03-02 | $233,459 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$2,669
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $2,669 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$90,177
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $90,177 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$27,676
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $27,676 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-03-02
$912,852
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $912,852 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-03-02
$51,066
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-03-02 | $51,066 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-03-02
$5,001
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $5,001 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-27
$92,934
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-27 | $92,934 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.8%
2026-02-04
$252,748
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.8%
|
2026-02-04 | $252,748 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 SellΔOwn -14.4%
2026-02-02
$489,126
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -14.4%
|
2026-02-02 | $489,126 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-02
$120,820
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-02 | $120,820 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$505,710
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $505,710 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2026-02-02
$203,554
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $203,554 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2026-02-02
$213,793
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-02 | $213,793 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2026-02-02
$93,707
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $93,707 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2026-02-02
$52,323
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-02-02 | $52,323 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -14.3%
2026-02-02
$250,483
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -14.3%
|
2026-02-02 | $250,483 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2026-02-02 | $33,658 | S | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Equity Compensation
2025-12-15
$0
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Equity Compensation
|
2025-12-15 | $0 | M | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Other
2025-12-15
$41,860
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Other
|
2025-12-15 | $41,860 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -10.5%
2025-12-15
$332,851
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -10.5%
|
2025-12-15 | $332,851 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -11.1%
2025-12-01
$302,133
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-12-01 | $302,133 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
10b5-1 Sell
2025-12-01
$50,091
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-12-01 | $50,091 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
LIN SUE-JEAN
• Director
Discretionary SellΔOwn -48.6%
2025-11-24
$777,956
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Discretionary SellΔOwn -48.6%
|
2025-11-24 | $777,956 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-11-24 | $54,222 | M | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-11-24 | $155,789 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-24
$1,485,755Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-24 | $1,485,755Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-11-21
$31,650
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-21 | $31,650 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Gilbert Halley E
• Director
Discretionary SellΔOwn -42.8%
2025-11-20
$455,442
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Discretionary SellΔOwn -42.8%
|
2025-11-20 | $455,442 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-11-20 | $91,772 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-19
$44,488
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-19 | $44,488 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-19
$27,647
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-19 | $27,647 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-13 | $28,792 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-11-13 | $233,459 | M | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-11-13 | $91,772 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Krishnamohan Neha
• Director
10b5-1 SellΔOwn -62.7%
2025-11-13
$910,702
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -62.7%
|
2025-11-13 | $910,702 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Discretionary SellΔOwn -16.2%
2025-11-06
$732,927
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Discretionary SellΔOwn -16.2%
|
2025-11-06 | $732,927 | S | Form 4 |
|
ARQT
M
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Other
2025-11-06
$62,790
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Other
|
2025-11-06 | $62,790 | M | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 SellΔOwn -14.9%
2025-11-06
$417,145
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -14.9%
|
2025-11-06 | $417,145 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
10b5-1 Sell
2025-11-05
$91,643
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-05 | $91,643 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2025-11-03
$64,425
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $64,425 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
CFO
Sell to Cover
|
2025-11-03 | $2,175 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2025-11-03
$1,753
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $1,753 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
Sell to Cover
2025-11-03
$283,647
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $283,647 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Welgus Howard G.
• Director
10b5-1 SellΔOwn -10.0%
2025-11-03
$252,669
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 SellΔOwn -10.0%
|
2025-11-03 | $252,669 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-03
$1,092
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $1,092 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Matsuda Masaru
• Officer • See Remarks
Sell to Cover
2025-11-03
$177,064
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $177,064 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Burnett Patrick
• Officer • See Remarks
Sell to Cover
2025-11-03
$381
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-11-03 | $381 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-28
$1,001,032Large
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-28 | $1,001,032Large | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2025-10-02
$6,172
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-10-02 | $6,172 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Edwards Larry Todd
• Officer • See Remarks
Sell to Cover
2025-10-02
$84,092
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
Sell to Cover
|
2025-10-02 | $84,092 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-02
$415,574
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-02 | $415,574 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-01 | $180,485 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-01 | $8,742 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$283,702
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $283,702 | S | Form 4 |
|
ARQT
S
Arcutis Biotherapeutics, Inc.
Watanabe Todd
• Officer • See Remarks
10b5-1 Sell
2025-10-01
$185,372
|
||||||
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-10-01 | $185,372 | S | Form 4 |
| ARQT |
Arcutis Biotherapeutics, Inc.
|
Director
Other
|
2025-10-01 | $16,030 | M | Form 4 |